JANSSEN PHARMACEUTICA NV
Turnhoutseweg 30 – Beerse – 2340
VAT: BE0403834160
http://www.janssenpharmaceutica.be
Complicit EU Projects
Within the Horizon 2020 (2014-2020) framework, JANSSEN PHARMACEUTICA NV has received € 250,560.0 for its participation in a total of 12 project(s) with a total cost of € 352,575,762.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2019-09-01 | 831458 | Trials@Home | 2024-08-31 | participant | € 0.0 | € 39,148,297 | 1 | 33 | CORDIS ↪ | |
| 2019-04-01 | 820755 | VALUE-Dx | public health · antibiotics · antibiotic resistance | 2024-09-30 | participant | € 0.0 | € 14,125,707 | 1 | 27 | CORDIS ↪ |
| 2017-10-01 | 765549 | M-GATE | pathology · neurology · machine learning · molecular biology | 2022-03-31 | participant | € 250,560.0 | € 3,961,159 | 1 | 11 | CORDIS ↪ |
| 2020-01-01 | 853992 | PharmaLedger | governance · big data · cryptography · business intelligence · health care services | 2022-12-31 | participant | € 0.0 | € 22,118,324 | 2 | 30 | CORDIS ↪ |
| 2020-11-01 | 945473 | ARDAT | drug safety · gene therapy · immunology · genomes · cells technologies | 2025-10-31 | participant | € 0.0 | € 25,490,491 | 1 | 34 | CORDIS ↪ |
| 2019-04-01 | 821520 | ConcePTION | governance · pharmaceutical drugs · obstetrics · ecosystems | 2024-03-31 | participant | € 0.0 | € 28,657,491 | 3 | 65 | CORDIS ↪ |
| 2017-10-01 | 777364 | EQIPD | neurobiology · data science · alzheimer · governance · machine learning | 2021-09-30 | participant | € 0.0 | € 9,360,691 | 1 | 31 | CORDIS ↪ |
| 2018-05-01 | 777492 | PIONEER | prostate cancer · big data | 2023-10-31 | participant | € 0.0 | € 13,549,159 | 1 | 38 | CORDIS ↪ |
| 2019-03-01 | 821558 | IMMUcan | databases · oncology · immunotherapy · microbiology | 2025-08-31 | participant | € 0.0 | € 35,779,304 | 1 | 31 | CORDIS ↪ |
| 2019-11-01 | 853966 | EU-PEARL | governance · tuberculosis | 2023-04-30 | participant | € 0.0 | € 25,938,047 | 1 | 41 | CORDIS ↪ |
| 2021-11-01 | 101034344 | EPND | neurobiology · data science · alzheimer · parkinson | 2026-10-31 | participant | € 0.0 | € 19,005,502 | 1 | 29 | CORDIS ↪ |
| 2018-06-01 | 777394 | AIMS-2-TRIALS | epilepsy · personalized medicine | 2025-05-31 | participant | € 0.0 | € 115,441,584 | 1 | 57 | CORDIS ↪ |
Within the Horizon Europe (2021-2027) framework, JANSSEN PHARMACEUTICA NV has received € 0.0 for its participation in a total of 1 project(s) with a total cost of € 37,263,739.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-01 | 101112053 | IMAGIO | liver cancer · lung cancer · magnetic resonance imaging · immunotherapy · ultrasound | 2027-04-30 | participant | € 0.0 | € 37,263,739 | 1 | 36 | CORDIS ↪ |
Within the FP7 (2007-2013) framework, JANSSEN PHARMACEUTICA NV has received € 223,630.0 for its participation in a total of 5 project(s) with a total cost of € 324,742,035.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2011-10-01 | 264872 | NAMASEN | nanotechnology · developmental biology · microelectronics · computational neuroscience · implants | 2015-09-30 | participant | € 223,630.0 | € 2,906,854 | 1 | 13 | CORDIS ↪ |
| 2011-02-01 | 115188 | PREDECT | bioreactors · lung cancer | 2016-04-30 | participant | € nan | € 21,020,760 | 1 | 21 | CORDIS ↪ |
| 2013-01-01 | 115523 | COMBACTE-NET | bacteriology · antibiotic resistance | 2021-02-28 | participant | € nan | € 220,954,266 | 1 | 39 | CORDIS ↪ |
| 2009-09-01 | 115008 | NEWMEDS | drug discovery · cognitive neuroscience · pharmaceutical drugs · schizophrenia · machine learning | 2015-02-28 | participant | € nan | € 24,849,675 | 1 | 20 | CORDIS ↪ |
| 2012-10-01 | 115439 | STEMBANCC | neurobiology · drug discovery · diabetes · stem cells · toxicology | 2018-03-31 | participant | € nan | € 55,010,480 | 2 | 38 | CORDIS ↪ |